A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
Clinical trial NCT04560998 · COMPLETED
Trial details
- NCT number
- NCT04560998
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2024-06-05
- Enrollment
- 792
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.